{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:56:08Z","timestamp":1794293768115,"version":"4.9.0"},"reference-count":35,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Bristol Myers Squibb"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2023,11,15]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Interstitial lung disease (ILD) is a severe extra-articular manifestation of rheumatoid arthritis (RA). The objectives of this study were to estimate mortality rate in patients with RA-ILD and identify factors affecting mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from a French national claims database (Syst\u00e8me National des Donn\u00e9es de Sant\u00e9) from 2013 to 2018 were analysed. Adults with an RA diagnosis (International Classification of Diseases (ICD)-10 codes M05, M06.0, M06.8 and M06.9) were included. ILD diagnosis was defined with ICD-10 code J84. Mortality rates were compared between patients with RA with and without ILD, using Cox proportional hazards regression, after matching 1:1 for age, sex, age at RA-ILD onset and RA duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 173 132 patients with RA, 4330 (3%) also had ILD (RA-ILD). After matching, RA-ILD was associated with an increased mortality rate (HR 3.4, 95% CI 3.1 to 3.9). The HR for mortality was greater for: patients aged &lt;75 years (HR 4.8, 95% CI 3.9 to 5.9) versus \u226575 years (HR 3.0, 95% CI 2.6 to 3.5); patients with ILD onset occurring before RA onset (HR 8.4, 95% CI 5.5 to 13.0) versus ILD onset occurring after RA onset (HR 2.9, 95% CI 2.6 to 3.3); and men (HR 5.2, 95% CI 4.4 to 6.2) versus women (HR 3.6, 95% CI 3.0 to 4.2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this nationwide cohort study, RA-ILD was associated with increased mortality rate (vs in patients with RA without ILD), notably for those aged &lt;75 years, those whose ILD preceded RA onset and men.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003491","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T12:22:20Z","timestamp":1701433340000},"page":"e003491","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":38,"title":["Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3766-9600","authenticated-orcid":false,"given":"Pierre-Antoine","family":"Juge","sequence":"first","affiliation":[{"name":"INSERM UMR 1152, Universit\u00e9 Paris Cit\u00e9, Paris, \u00cele-de-France, France"},{"name":"Service de Rhumatologie, H\u00f4pital Bichat - Claude-Bernard, AP-HP, Paris, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidwine","family":"W\u00e9meau-Stervinou","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Immuno-Allergologie, CHRU de Lille, Lille, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Ottaviani","sequence":"additional","affiliation":[{"name":"INSERM UMR 1152, Universit\u00e9 Paris Cit\u00e9, Paris, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Desjeux","sequence":"additional","affiliation":[{"name":"Real World Digital Contract Research Company, Sano\u00efa, G\u00e9menos, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Zhuo","sequence":"additional","affiliation":[{"name":"Worldwide Health Economics and Outcomes Research, Bristol Myers Squibb, Princeton, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Vannier-Moreau","sequence":"additional","affiliation":[{"name":"Medical ImmunoScience\/Rhumatologie, Bristol Myers Squibb, Rueil-Malmaison, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5528-8070","authenticated-orcid":false,"given":"Ren\u00e9-Marc","family":"Flipo","sequence":"additional","affiliation":[{"name":"Service de Rhumatologie, CHRU de Lille, Lille, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Crestani","sequence":"additional","affiliation":[{"name":"Service de pneumologie A, H\u00f4pital Bichat - Claude Bernard, AP-HP, Paris, Ile de France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4814-0307","authenticated-orcid":false,"given":"Philippe","family":"Dieud\u00e9","sequence":"additional","affiliation":[{"name":"INSERM UMR 1152, Universit\u00e9 Paris Cit\u00e9, Paris, \u00cele-de-France, France"},{"name":"Service de Rhumatologie, H\u00f4pital Bichat - Claude-Bernard, AP-HP, Paris, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"2025090312534082000_9.4.e003491.1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol Int"},{"key":"2025090312534082000_9.4.e003491.2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez177"},{"key":"2025090312534082000_9.4.e003491.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.8.722"},{"key":"2025090312534082000_9.4.e003491.4","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.2.9609016"},{"key":"2025090312534082000_9.4.e003491.5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1492-5"},{"key":"2025090312534082000_9.4.e003491.6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu165"},{"key":"2025090312534082000_9.4.e003491.7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq035"},{"key":"2025090312534082000_9.4.e003491.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201004-0622OC"},{"key":"2025090312534082000_9.4.e003491.9","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/406927","article-title":"Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease","volume":"2013","author":"Chen","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"2025090312534082000_9.4.e003491.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211138"},{"key":"2025090312534082000_9.4.e003491.11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000502551","article-title":"Rheumatoid arthritis-associated interstitial lung disease: clinical characteristics and predictors of mortality","volume":"98","author":"Hyldgaard","year":"2019","journal-title":"Respiration"},{"key":"2025090312534082000_9.4.e003491.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.27405"},{"key":"2025090312534082000_9.4.e003491.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00357-2015"},{"key":"2025090312534082000_9.4.e003491.14","first-page":"344","article-title":"Patterns of interstitial lung disease and mortality in rheumatoid arthritis","volume":"56","author":"Zamora-Legoff","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312534082000_9.4.e003491.15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.39971","article-title":"Progressive decline of lung function in rheumatoid arthritis-associated interstitial lung disease","volume":"69","author":"Zamora-Legoff","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025090312534082000_9.4.e003491.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.04.061"},{"key":"2025090312534082000_9.4.e003491.17","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00092309"},{"key":"2025090312534082000_9.4.e003491.18","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1093\/rheumatology\/keac208","article-title":"The impact of disease severity measures on survival in U.S. Veterans with rheumatoid arthritis-associated interstitial lung disease","volume":"61","author":"Brooks","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312534082000_9.4.e003491.19","unstructured":"National Institute for statistics and economic studies. 2021. Available: https:\/\/www.insee.fr\/en\/accueil [Accessed 20 Oct 2021]."},{"key":"2025090312534082000_9.4.e003491.20","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-021-02655-z","article-title":"Validation of an algorithm to identify incident interstitial lung disease in patients with rheumatoid arthritis","volume":"24","author":"Meehan","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2025090312534082000_9.4.e003491.21","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171315"},{"key":"2025090312534082000_9.4.e003491.22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa836"},{"key":"2025090312534082000_9.4.e003491.23","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1513\/AnnalsATS.202102-115OC","article-title":"Rheumatoid arthritis and associated interstitial lung disease: mortality rates and trends","volume":"18","author":"Jeganathan","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2025090312534082000_9.4.e003491.24","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1007\/s10067-018-4314-9","article-title":"Chronic lung disease in U.S. veterans with rheumatoid arthritis and the impact on survival","volume":"37","author":"England","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2025090312534082000_9.4.e003491.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3781-7"},{"key":"2025090312534082000_9.4.e003491.26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02314-2016","article-title":"Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis","volume":"49","author":"Juge","year":"2017","journal-title":"Eur Respir J"},{"key":"2025090312534082000_9.4.e003491.27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(14)70124-9","article-title":"Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation","volume":"2","author":"Stuart","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2025090312534082000_9.4.e003491.28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02533-2020","article-title":"Two sides of the same coin? A review of the similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease","volume":"57","author":"Matson","year":"2021","journal-title":"Eur Respir J"},{"key":"2025090312534082000_9.4.e003491.29","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/rheumatology\/keab552","article-title":"The attitudes and practices of physicians caring for patients with rheumatoid arthritis-associated interstitial lung disease: an international survey","volume":"61","author":"Solomon","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312534082000_9.4.e003491.30","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00337-2020","article-title":"Methotrexate and rheumatoid arthritis associated interstitial lung disease","volume":"57","author":"Juge","year":"2021","journal-title":"Eur Respir J"},{"key":"2025090312534082000_9.4.e003491.31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/rheumatology\/keaa327","article-title":"Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study","volume":"60","author":"Ibfelt","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312534082000_9.4.e003491.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"key":"2025090312534082000_9.4.e003491.33","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s10067-021-06040-8","article-title":"Rheumatoid arthritis-related interstitial lung disease (RA-ILD): a possible association between disease activity and prognosis","volume":"41","author":"Rojas-Serrano","year":"2022","journal-title":"Clin Rheumatol"},{"key":"2025090312534082000_9.4.e003491.34","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s10067-022-06245-5","article-title":"Can we finally exonerate methotrexate as a factor in causing or exacerbating fibrotic interstitial lung disease in patients with rheumatoid arthritis","volume":"41","author":"Mehta","year":"2022","journal-title":"Clin Rheumatol"},{"key":"2025090312534082000_9.4.e003491.35","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0288"}],"updated-by":[{"DOI":"10.1136\/rmdopen-2023-003491corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000}}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:53:49Z","timestamp":1756929229000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12,1]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/rmdopen-2023-003491"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003491","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}